hematoporphyrin has been researched along with Kahler Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berenbaum, MC; Bonnett, R; Scourides, PA | 1 |
| Berki, T; Lakos, Z | 1 |
| Blau, W; McHale, AP; McHale, ML | 1 |
3 other study(ies) available for hematoporphyrin and Kahler Disease
| Article | Year |
|---|---|
In vivo biological activity of the components of haematoporphyrin derivative.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Hematoporphyrin Derivative; Hematoporphyrins; Hydrolysis; Mice; Mice, Inbred BALB C; Multiple Myeloma; Necrosis; Neoplasms, Experimental; Photochemotherapy; Radiation-Sensitizing Agents; Time Factors | 1982 |
Effect of haematoporphyrin-induced photosensitization on lipid membranes.
Topics: Animals; Cell Division; Cell Line; Cell Membrane; Dose-Response Relationship, Drug; Fluorescence Polarization; Hematoporphyrins; Light; Liposomes; Mice; Multiple Myeloma; Phosphatidylcholines; Photosensitizing Agents; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1995 |
The effect of hematoporphyrin derivative and human erythrocyte ghost encapsulated hematoporphyrin derivative on a mouse myeloma cell line.
Topics: Cell Fusion; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Erythrocyte Membrane; Hematoporphyrin Derivative; Hematoporphyrins; Laser Therapy; Multiple Myeloma; Tumor Cells, Cultured | 1988 |